Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Moriarty John B. Director active across 3 companies, notably ALEXION PHARMACEUTICALS INC. Aggregated, 15 reports have been logged. Split: 0 buy · 9 sells. Total volume traded: €70k. History available since 9 August 2023. The latest transaction was filed on 17 December 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Moriarty John B
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations15 total
56,000 shares0Common StockSEC:0001599901-25-000217:0
2,245 shares@ US$36.21100.0% of flowCommon StockSEC:0001599901-25-000138:0
25,000 shares0Common StockSEC:0001599901-25-000025:0
25,000 shares0Common StockSEC:0001599901-24-000123:0
675 sharesCommon StockSEC:0001140361-24-003540:0
22,297 shares@ US$37.00100.0% of flowCommon StockSEC:0001628280-23-028878:0
11,763 sharesCommon Stock, par value $.0001 per shareSEC:0000899866-16-000247:0
500 sharesCommon Stock, par value $.0001 per shareSEC:0000899866-16-000247:1
400 sharesCommon Stock, par value $.0001 per shareSEC:0000899866-16-000247:2
200 sharesCommon Stock, par value $.0001 per shareSEC:0000899866-16-000247:3
436 sharesCommon Stock, par value $.0001 per shareSEC:0000899866-16-000247:4
433 sharesCommon Stock, par value $.0001 per shareSEC:0000899866-16-000247:5
137 sharesCommon Stock, par value $.0001 per shareSEC:0000899866-16-000247:6
78 sharesCommon Stock, par value $.0001 per shareSEC:0000899866-16-000247:7
2,418 sharesCommon Stock, par value $.0001 per shareSEC:0000899866-16-000247:8
About Moriarty John B
Moriarty John B is a declarant linked to ALEXION PHARMACEUTICALS INC, Avidity Biosciences, Inc., and Mirati Therapeutics, Inc., where the listed roles are EVP & General Counsel, Chief Legal Officer, and Chief Legal Officer. He has 14 filings in total, and across the recent filings available from 2016-02-08 to 2025-08-05, the reported sell volume is EUR 70175 and the modal transaction nature is Sell.